|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.55 CNY | +0.35% |
|
+1.79% | -4.89% |
| Apr. 15 | Luyan Pharma Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 2023 | Luyan Pharma Co.,Ltd. Announces Board Appointments | CI |
Luyan Pharma Co.,Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 14,775.16 million compared to CNY 14,323.77 million a year ago. Revenue was CNY 14,775.16 million compared to CNY 14,323.77 million a year ago.
Net income was CNY 261.98 million compared to CNY 250.86 million a year ago. Basic earnings per share from continuing operations was CNY 0.67 compared to CNY 0.65 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -4.89% | 458M | |
| +17.35% | 71.39B | |
| +2.39% | 25.1B | |
| +5.38% | 8.59B | |
| +6.69% | 8.19B | |
| -20.96% | 7.91B | |
| +0.49% | 4.54B | |
| +17.12% | 4.31B | |
| -2.61% | 3.86B | |
| +22.08% | 3.64B |
LUYAN PHARMA CO.,LTD. 
